BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11553607)

  • 1. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.
    Planelles L; Thomas MC; Alonso C; López MC
    Infect Immun; 2001 Oct; 69(10):6558-63. PubMed ID: 11553607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection.
    Morell M; Thomas MC; Caballero T; Alonso C; López MC
    Vaccine; 2006 Nov; 24(49-50):7046-55. PubMed ID: 16901590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
    Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K
    Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
    Miller MJ; Wrightsman RA; Manning JE
    Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene.
    Qazi KR; Wikman M; Vasconcelos NM; Berzins K; Ståhl S; Fernández C
    Vaccine; 2005 Jan; 23(9):1114-25. PubMed ID: 15629354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
    Garg N; Tarleton RL
    Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii-derived heat shock protein 70 gene.
    Kikumura A; Fang H; Mun HS; Uemura N; Makino M; Sayama Y; Norose K; Aosai F
    Parasitol Int; 2010 Jun; 59(2):105-11. PubMed ID: 20346412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes.
    Marañón C; Thomas MC; Planelles L; López MC
    Mol Immunol; 2001 Aug; 38(4):279-87. PubMed ID: 11566321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.
    Sepulveda P; Hontebeyrie M; Liegeard P; Mascilli A; Norris KA
    Infect Immun; 2000 Sep; 68(9):4986-91. PubMed ID: 10948115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo.
    Ye J; Chen GS; Song HP; Li ZS; Huang YY; Qu P; Sun YJ; Zhang XM; Sui YF
    Cancer Immunol Immunother; 2004 Sep; 53(9):825-34. PubMed ID: 15127237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients.
    Marañón C; Egui A; Carrilero B; Thomas MC; Pinazo MJ; Gascón J; Segovia M; López MC
    Microbes Infect; 2011 Nov; 13(12-13):1025-32. PubMed ID: 21704723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo.
    Ma JH; Sui YF; Ye J; Huang YY; Li ZS; Chen GS; Qu P; Song HP; Zhang XM
    Cancer Immunol Immunother; 2005 Sep; 54(9):907-14. PubMed ID: 15756604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.
    Tzelepis F; de Alencar BC; Penido ML; Gazzinelli RT; Persechini PM; Rodrigues MM
    Infect Immun; 2006 Apr; 74(4):2477-81. PubMed ID: 16552083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.
    Pereira-Chioccola VL; Costa F; Ribeirão M; Soares IS; Arena F; Schenkman S; Rodrigues MM
    Parasite Immunol; 1999 Feb; 21(2):103-10. PubMed ID: 10101720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.